NASDAQ:NOVN - Novan Stock Price, Forecast & News

Novan trades on the NASDAQ under the ticker symbol "NOVN."

Novan Inc (NASDAQ:NOVN) issued its quarterly earnings data on Friday, May, 12th. The company reported ($0.73) EPS for the quarter, missing analysts' consensus estimates of ($0.49) by $0.24. The firm had revenue of $0.10 million for the quarter, compared to analyst estimates of $10.80 million. View Novan's Earnings History.

Novan is scheduled to release their next quarterly earnings announcement on Wednesday, March 25th 2020. View Earnings Estimates for Novan.

3 brokerages have issued twelve-month price targets for Novan's shares. Their forecasts range from $0.50 to $1.50. On average, they anticipate Novan's share price to reach $1.00 in the next year. This suggests a possible upside of 101.1% from the stock's current price. View Analyst Price Targets for Novan.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Novan in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Novan.

Media stories about NOVN stock have been trending negative this week, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Novan earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Novan.

Novan saw a decline in short interest in January. As of January 31st, there was short interest totalling 188,700 shares, a decline of 77.7% from the January 15th total of 847,400 shares. Based on an average daily volume of 405,000 shares, the days-to-cover ratio is currently 0.5 days. Currently, 1.1% of the company's stock are short sold. View Novan's Current Options Chain.

Some companies that are related to Novan include Acasti Pharma (ACST), SUMMIT THERAPEU/S (SMMT), Bellicum Pharmaceuticals (BLCM), Acer Therapeutics (ACER), Vascular Biogenics (VBLT), Forward Pharma A/S (FWP), resTORbio (TORC), PLx Pharma (PLXP), Hoth Therapeutics (HOTH), IntelGenx Technologies (IGXT), Zafgen (ZFGN), Adamis Pharmaceuticals (ADMP), Bellerophon Therapeutics (BLPH), Merrimack Pharmaceuticals (MACK) and Pharmaxis (PXSLY).

Based on aggregate information from My MarketBeat watchlists, some companies that other Novan investors own include Melinta Therapeutics (MLNT), SCYNEXIS (SCYX), MannKind (MNKD), Vuzix (VUZI), Valero Energy (VLO), Washington Prime Group (WPG), Biocept (BIOC), Cirrus Logic (CRUS), Heron Therapeutics (HRTX) and Intuitive Surgical (ISRG).

(NOVN) raised $46 million in an initial public offering (IPO) on Wednesday, September 21st 2016. The company issued 3,800,000 shares at $11.00-$13.00 per share. Piper Jaffray served as the underwriter for the IPO and JMP Securities and Wedbush PacGrow were co-managers.

Novan's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Cardinal Capital Management (0.19%) and Vigilant Capital Management LLC (0.11%). Company insiders that own Novan stock include G Kelly Martin, John M Gay, John W Palmour, Life Sciences Holdings L Malin, Paula B Stafford and Robert Alexander Ingram. View Institutional Ownership Trends for Novan.

NOVN stock was bought by a variety of institutional investors in the last quarter, including Cardinal Capital Management and Vigilant Capital Management LLC. Company insiders that have bought Novan stock in the last two years include G Kelly Martin, John M Gay, John W Palmour, Paula B Stafford and Robert Alexander Ingram. View Insider Buying and Selling for Novan.

Shares of NOVN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of NOVN stock can currently be purchased for approximately $0.50.

Novan has a market capitalization of $13.29 million and generates $5.99 million in revenue each year. The company earns $-12,670,000.00 in net income (profit) each year or ($1.13) on an earnings per share basis. Novan employs 47 workers across the globe.View Additional Information About Novan.

The official website for Novan is http://www.novantherapeutics.com/.

Novan's mailing address is 4105 HOPSON ROAD, MORRISVILLE NC, 27560. The company can be reached via phone at 919-485-8080 or via email at [email protected]